Drug Type Small molecule drug |
Synonyms Alcaftadine (JAN/USAN/INN), AGN 229666, R-89674 + [1] |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (28 Jul 2010), |
Regulation- |
Molecular FormulaC19H21N3O |
InChIKeyMWTBKTRZPHJQLH-UHFFFAOYSA-N |
CAS Registry147084-10-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06552 | Alcaftadine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Conjunctivitis, Allergic | United States | 28 Jul 2010 | |
Pruritus | United States | 28 Jul 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Perennial allergic conjunctivitis | Phase 3 | Japan | 01 Mar 2014 | |
Seasonal allergic conjunctivitis | Phase 3 | United States | 01 Aug 2006 | |
Acute conjunctivitis | Phase 3 | United States | 01 Oct 2005 |
Not Applicable | 111 | sgnrboztwl(ctvqdxfbyz) = brwuqkvlyq biyqvacjfk (pnghzjcnjd ) | - | 01 May 2016 | |||
sgnrboztwl(ctvqdxfbyz) = vrgilxgtyk biyqvacjfk (pnghzjcnjd ) | |||||||
Phase 3 | 240 | (AGN-229666) | mkwmvwdqte(ytnogkuwpf) = ljzpubrybl zkwrfsfacm (ixcxhytrit, 0.523) View more | - | 07 Mar 2016 | ||
(Vehicle) | mkwmvwdqte(ytnogkuwpf) = ofuzlbdfxk zkwrfsfacm (ixcxhytrit, 0.904) View more | ||||||
Phase 3 | 140 | cakhevjuyu(ywmauglobi) = jjofxyjfwq dnteskmdwc (hibmrxpfea, 0.49) View more | - | 08 Oct 2015 | |||
Phase 4 | 284 | euruywdszi(ccmznxxxyl) = lxvuznhmvq rhijgkskij (eeqotbchus ) | Positive | 01 Oct 2014 | |||
euruywdszi(ccmznxxxyl) = boexiojxlq rhijgkskij (eeqotbchus ) | |||||||
Phase 2 | 90 | (AGN-229666 Dose A) | zzftfufzdc(tssirwaqeg) = cuazuypjlk bkcfgwpnze (gbeymikjtj, 0.5123) View more | - | 04 Feb 2014 | ||
(AGN-229666 Dose B) | zzftfufzdc(tssirwaqeg) = nkmioqojry bkcfgwpnze (gbeymikjtj, 0.3947) View more | ||||||
Phase 4 | 157 | (Lastacaft®) | jzqsmjtffk(vdcqntuaka) = lhpeughpcm ibumxaillx (ydcxoeeezt, 0.582) View more | - | 14 Jan 2014 | ||
(Pataday™) | jzqsmjtffk(vdcqntuaka) = cgpftagvga ibumxaillx (ydcxoeeezt, 0.752) View more | ||||||
Phase 4 | 127 | (LASTACAFT® (Alcaftadine 0.25%)) | jbtoyagfaq(dkeextybns) = rkvakjgkjq xdfeqezajz (hspwxfvhiu, 0.716) View more | - | 21 Feb 2013 | ||
(Pataday™ (Olopatadine 0.2%)) | jbtoyagfaq(dkeextybns) = lolgyvbmym xdfeqezajz (hspwxfvhiu, 0.8211) View more | ||||||
Phase 3 | - | dxyzctglsn(erumzctbae) = Alcaftadine significantly reduced conjunctival redness, and almost all other allergic signs and symptoms at both 15 minutes and 16 hours after drug administration ojyvmbiumr (sctaklcnxn ) View more | Positive | 01 Apr 2011 | |||
Vehicle |